CLINICAL_TRIALS
trial_result
· 2010-07-29
Clinical Trial Update: A 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With Schizophrenia [Phase 3]
Summary
Phase 3 trial comparing the metabolic effects of paliperidone ER versus olanzapine in patients with schizophrenia. Results were posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen-Cilag International NV | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2010-07-29